Astera Labs, Inc. $ALAB Shares Sold by Royal Bank of Canada

Royal Bank of Canada reduced its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 21.6% during the first quarter, Holdings Channel.com reports. The firm owned 132,292 shares of the company’s stock after selling 36,506 shares during the period. Royal Bank of Canada’s holdings in Astera Labs were worth $14,499,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of ALAB. Empowered Funds LLC grew its position in Astera Labs by 5.1% in the 1st quarter. Empowered Funds LLC now owns 9,606 shares of the company’s stock valued at $1,053,000 after buying an additional 462 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in shares of Astera Labs by 79.8% during the 1st quarter. The Manufacturers Life Insurance Company now owns 538,205 shares of the company’s stock worth $58,987,000 after buying an additional 238,911 shares in the last quarter. Estuary Capital Management LP bought a new stake in shares of Astera Labs during the 1st quarter worth about $18,737,000. Quantinno Capital Management LP lifted its stake in shares of Astera Labs by 49.8% in the 1st quarter. Quantinno Capital Management LP now owns 42,150 shares of the company’s stock worth $4,620,000 after acquiring an additional 14,010 shares during the period. Finally, ABS Direct Equity Fund LLC bought a new position in shares of Astera Labs in the first quarter valued at approximately $263,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Transactions at Astera Labs

In other news, General Counsel Philip Mazzara sold 796 shares of the company’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $291.03, for a total value of $231,659.88. Following the transaction, the general counsel owned 103,343 shares in the company, valued at $30,075,913.29. This represents a 0.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Bethany Mayer sold 686 shares of the stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total transaction of $270,997.44. Following the completion of the sale, the director directly owned 5,550 shares of the company’s stock, valued at $2,192,472. This trade represents a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 1,244,395 shares of company stock worth $358,865,571. 10.40% of the stock is currently owned by company insiders.

Astera Labs Stock Performance

NASDAQ ALAB opened at $334.17 on Friday. The firm’s 50 day moving average price is $360.45 and its two-hundred day moving average price is $235.27. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The stock has a market cap of $57.98 billion, a price-to-earnings ratio of 165.43, a PEG ratio of 3.84 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Analyst Ratings Changes

ALAB has been the topic of a number of research analyst reports. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Roth Capital reiterated a “buy” rating and set a $450.00 price target on shares of Astera Labs in a research report on Wednesday. Bank of America boosted their price objective on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. Finally, Barclays upped their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Thirteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $325.25.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.